Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase - PubMed (original) (raw)

Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase

Sirichai Adisakwattana et al. Plant Foods Hum Nutr. 2011 Jun.

Abstract

Inhibition of α-glucosidase and pancreatic α-amylase is one of the therapeutic approaches for delaying carbohydrate digestion, resulting in reduced postprandial glucose. The aim of this study was to evaluate the phytochemical analysis and the inhibitory effect of various cinnamon bark species against intestinal α-glucosidase and pancreatic α-amylase. The results showed that the content of total phenolic, flavonoid, and condensed tannin ranged from 0.17 to 0.21 g gallic acid equivalent/g extract, from 48.85 to 65.52 mg quercetin equivalent/g extract, and from 0.12 to 0.15 g catechin equivalent/g extract, respectively. The HPLC fingerprints of each cinnamon species were established. Among cinnamon species, Thai cinnamon extract was the most potent inhibitor against the intestinal maltase with the IC(50) values of 0.58 ± 0.01 mg/ml. The findings also showed that Ceylon cinnamon was the most effective intestinal sucrase and pancreatic α-amylase inhibitor with the IC(50) values of 0.42 ± 0.02 and 1.23 ± 0.02 mg/ml, respectively. In addition, cinnamon extracts produced additive inhibition against intestinal α-glucosidase and pancreatic α-amylase when combined with acarbose. These results suggest that cinnamon bark extracts may be potentially useful for the control of postprandial glucose in diabetic patients through inhibition of intestinal α-glucosidase and pancreatic α-amylase.

PubMed Disclaimer

Similar articles

• Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves.
  Toma A, Makonnen E, Mekonnen Y, Debella A, Addisakwattana S. Toma A, et al. BMC Complement Altern Med. 2014 Jun 3;14:180. doi: 10.1186/1472-6882-14-180. BMC Complement Altern Med. 2014. PMID: 24890563 Free PMC article.
• In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase.
  Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. Adisakwattana S, et al. BMC Complement Altern Med. 2012 Jul 31;12:110. doi: 10.1186/1472-6882-12-110. BMC Complement Altern Med. 2012. PMID: 22849553 Free PMC article.
• Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in SD rats model.
  Kim SH, Jo SH, Kwon YI, Hwang JK. Kim SH, et al. Int J Mol Sci. 2011;12(6):3757-69. doi: 10.3390/ijms12063757. Epub 2011 Jun 8. Int J Mol Sci. 2011. PMID: 21747704 Free PMC article.
• Measuring key human carbohydrate digestive enzyme activities using high-performance anion-exchange chromatography with pulsed amperometric detection.
  Barber E, Houghton MJ, Visvanathan R, Williamson G. Barber E, et al. Nat Protoc. 2022 Dec;17(12):2882-2919. doi: 10.1038/s41596-022-00736-0. Epub 2022 Sep 30. Nat Protoc. 2022. PMID: 36180531 Review.
• Inhibitory effect of extracts from edible parts of nuts on α-amylase activity: a systematic review.
  Farazi M, Houghton MJ, Cardoso BR, Murray M, Williamson G. Farazi M, et al. Food Funct. 2024 May 20;15(10):5209-5223. doi: 10.1039/d4fo00414k. Food Funct. 2024. PMID: 38717256 Review.

Cited by

• Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial.
  Moreira FD, Reis CEG, Gallassi AD, Moreira DC, Welker AF. Moreira FD, et al. PLoS One. 2024 Oct 9;19(10):e0311501. doi: 10.1371/journal.pone.0311501. eCollection 2024. PLoS One. 2024. PMID: 39383145 Free PMC article. Clinical Trial.
• Screening of Multitarget Compounds against Acetaminophen Hepatic Toxicity Using In Silico, In Vitro, and In Vivo Approaches.
  Ali M, Asghar E, Ali W, Mustafa G, Ansari IA, Zia S, Ansari SA, Khan S. Ali M, et al. Molecules. 2024 Jan 16;29(2):428. doi: 10.3390/molecules29020428. Molecules. 2024. PMID: 38257341 Free PMC article.
• Identification and in vitro Characterization of Novel Antidiabetic Peptides Released Enzymatically from Peanut Protein.
  Al-Bukhaiti WQ, Al-Dalali S, Li H, Yao L, Abed SM, Zhao L, Qiu SX. Al-Bukhaiti WQ, et al. Plant Foods Hum Nutr. 2024 Mar;79(1):66-72. doi: 10.1007/s11130-023-01118-x. Epub 2023 Nov 23. Plant Foods Hum Nutr. 2024. PMID: 37994988
• Prospective Nutraceutical Effects of Cinnamon Derivatives Against Insulin Resistance in Type II Diabetes Mellitus-Evidence From the Literature.
  Mohsin SN, Saleem F, Humayun A, Tanweer A, Muddassir A. Mohsin SN, et al. Dose Response. 2023 Sep 10;21(3):15593258231200527. doi: 10.1177/15593258231200527. eCollection 2023 Jul-Sep. Dose Response. 2023. PMID: 37701673 Free PMC article. Review.
• In vitro and in vivo antioxidant and antihyperglycemic potentials of phenolic fractions of Syzygium zeylanicum (L.) DC trunk-bark.
  Nguyen MT, Thi BHB, Maskey S, Tran MD, Nguyen QV. Nguyen MT, et al. Food Sci Nutr. 2023 Apr 26;11(7):3875-3884. doi: 10.1002/fsn3.3373. eCollection 2023 Jul. Food Sci Nutr. 2023. PMID: 37457151 Free PMC article.

References

1. 1. Diabetes Res Clin Pract. 1998 Jul;40 Suppl:S51-5 - PubMed
2. 1. Diabetes Res Clin Pract. 2005 Mar;67(3):204-10 - PubMed
3. 1. J Med Food. 2005 Summer;8(2):266-8 - PubMed
4. 1. Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2344-9 - PubMed
5. 1. Dis Mon. 2009 Jun;55(6):327-35 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer